儿童脑瘤中的EZHIP:从表观遗传模仿到治疗脆弱性
Tiziana Servidei1, Serena Gentile1, Alessandro Sgambato2,3
1Pediatric Oncology Unit, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy.
International journal of molecular sciences
|January 28, 2026
概括
增强性凝血同类抑制蛋白 (EZHIP) 通过抑制PRC2和改变H3K27me3.3驱动激进的儿科脑瘤. 埃齐希普 (Ezhip) 是一个国家.
科学领域:
- 分子生物学分子生物学
- 癌症生物学 癌症生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- EZHIP是一种特异于的蛋白质,通常仅限于生殖细胞.
- 异常的EZHIP再表达与侵略性的儿科大脑瘤有关,例如后表膜瘤A和扩散的中线质瘤.
- 这些瘤表现出H3K27me3的丧失,这是一个由Polycomb抑制复合体2 (PRC2) 调节的标记.
研究的目的:
- 审查目前对EZHIP功能,作用机制和癌症中的作用的理解.
- 探索EZHIP在表观遗传调节,新陈代谢,DNA修复和染色质组织中的参与.
- 讨论针对恶性瘤的EZHIP的临床意义和治疗潜力.
主要方法:
- 文献综述整合了关于EZHIP的当前研究.
- 分析EZHIP的PRC2抑制机制以及对H3K27me3.3的影响.
- 检查EZHIP在各种癌症中的作用,包括儿科脑瘤和骨肉瘤.
主要成果:
- EZHIP抑制PRC2,导致全基因组H3K27me3的改变并影响细胞命运.
- EZHIP 本质上是无序的结构,可以实现多样化的交互和功能.
- EZHIP是多种癌症的致癌驱动因素,包括后脑瘤和骨肉瘤.
结论:
- EZHIP在儿童和成人恶性瘤中起着重要作用,特别是在EZHIP驱动的后脑瘤中.
- 针对EZHIP或其相关的表观遗传和代谢途径提供了治疗机会.
- 了解EZHIP的多方面的作用对于推进精密瘤学和管理瘤演变至关重要.
关键词:
这是DMG的DMG.在EPN-PFA中.埃齐希普 (Ezhip) 是一个国家.改变了H3的情况.H3K27M 在线播放在 PRC2 中,PRC2 是 PRC2 的第一个类型.表观遗传学是指表观遗传学.本质上是无序的蛋白质.更多相关视频
07:44Establishment of Orthotopic Patient-derived Xenograft Models for Brain Tumors using a Stereotaxic Device
Published on: May 2, 2025
894
07:39Co-culture of Glutamatergic Neurons and Pediatric High-Grade Glioma Cells Into Microfluidic Devices to Assess Electrical Interactions
Published on: November 17, 2021
4.0K
相关概念视频
01:13Nonconscious Mimicry
5.1K
Nonconscious mimicry occurs when individuals alter their mannerisms to match the behaviors and expressions of those nearby, without intention.
5.1K
01:46Epigenetic Regulation
33.7K
Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
33.7K
01:37Epigenetic Regulation
3.9K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.9K
01:13Therapeutic Index
6.7K
The therapeutic index of a drug is a key parameter in pharmacology that quantifies the relative safety of a drug by calculating the ratio between the dose that causes toxicity in half the population (50%) to the dose that proves to be effective for half the population (50%). It provides a spectrum of doses for a particular drug ranging from effective to potentially toxic. To illustrate, consider an anticoagulant agent like warfarin. It possesses a narrow window within its therapeutic index to...
6.7K
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
225
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
225
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
285
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
285